358
Views
11
CrossRef citations to date
0
Altmetric
Reviews

Accuracy of Intraocular Lens Power Calculation in Eyes Filled with Silicone Oil

ORCID Icon &
Pages 392-397 | Received 23 Jan 2019, Accepted 18 Jun 2019, Published online: 01 Jul 2019
 

ABSTRACT

Silicone oil (SO) is used mainly when managing complex retinal detachments, commonly with proliferative vitreoretinopathy, as well as a hemostatic agent in proliferative diabetic retinopathy. Combined lens exchange and pars plana vitrectomy remains preferred by many surgeons; however, sequential surgery might be advantageous to minimize the postoperative anterior chamber inflammatory response, particularly in proliferative diabetic retinopathy or retinal detachment. The aim of the study was to evaluate the optimal method of intraocular lens (IOL) calculation in eyes filled with SO.

Different techniques are employed for axial length assessment in eyes filled with SO, including preoperative A-scan applanation or immersion biometry, partial coherence interferometry (PCI), or less commonly computed tomography, magnetic resonance imaging, or intraoperative retinoscopy/biometry after SO removal. PCI might provide better refractive outcomes compared to ultrasound measurements, however, the quality of presented evidence is low. Bias in calculation may be a result of limited vitreous base removal during vitrectomy, partial filling of the vitreous chamber with SO and measurements in supine position, macular edema or detachment, selection of an inappropriate IOL calculation formulas and sulcus IOL placement.

Clinicians should consider that even when employing optical biometry and correct calculation formulas only a third of eyes filled with silicone oil might achieve ± 1.0 D of target refraction, compared to 97.2% of normal eyes. We would recommend performing optical biometry before the application of SO; if this is impossible, measurement of the second eye or biometry after SO removal is an alternative. Implantation of a convex-plano monofocal polymethyl methacrylate or foldable hydrophobic acrylic IOL with large optic diameter is advised in these patients.

DECLARATION OF INTEREST

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

Additional information

Funding

Dr. Kanclerz reports non-financial support from Visim and Optopol Technologies. Dr. Grzybowski reports non-financial support from Bayer, non-financial support from Novartis, non-financial support from Alcon, personal fees and non-financial support from Valeant, grants from Zeiss, personal fees and non-financial support from Santen, outside the submitted work.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.